会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 32. 发明申请
    • PIPERIDINE DERIVATIVES USEFUL AS CCR5 ANTAGONISTS
    • 哌啶衍生物作为CCR5拮抗剂有用
    • US20080095740A1
    • 2008-04-24
    • US11925119
    • 2007-10-26
    • Michael MillerJack Scott
    • Michael MillerJack Scott
    • A61K31/506A61K31/538A61K31/551A61K31/675A61K31/7056A61K31/7068A61K31/7072A61K31/708A61K38/20A61P31/18
    • C07D401/14
    • The present invention provides a compound of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein the various moieties are as defined in the specification. The present invention also provides pharmaceutical compositions containing the compound of this invention, and methods of treatment using the compound of this invention. The invention also relates to the use of a combination of a compound of this invention and one or more antiviral or other agents useful in the treatment of Human Immunodeficiency Virus (HIV). The invention further relates to the use of a compound of this invention, alone or in combination with another agent, in the treatment of solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis.
    • 本发明提供下式的化合物或其药学上可接受的盐或溶剂合物,其中各种部分如说明书中所定义。 本发明还提供含有本发明化合物的药物组合物和使用本发明化合物的治疗方法。 本发明还涉及本发明化合物与一种或多种可用于治疗人类免疫缺陷病毒(HIV)的抗病毒剂或其它药剂的组合的用途。 本发明还涉及本发明化合物单独或与另一种药剂组合用于治疗实体器官移植排斥,移植物抗宿主病,关节炎,类风湿性关节炎,炎症性肠病,特应性皮炎,牛皮癣 ,哮喘,过敏或多发性硬化。
    • 37. 发明申请
    • Color EL display system with improved resolution
    • 彩色EL显示系统,分辨率提高
    • US20070257945A1
    • 2007-11-08
    • US11429839
    • 2006-05-08
    • Michael MillerMichael MurdochRonald Cok
    • Michael MillerMichael MurdochRonald Cok
    • G09G5/02
    • G09G3/2003G09G3/3208G09G2300/0452G09G2340/0457G09G2340/06
    • A full color electro-luminescent display system, comprising: a display device comprised of a plurality of red, green, blue light-emitting elements and at least one additional color of light-emitting element having luminance efficiency greater than at least one of the red, green and blue light-emitting elements, wherein the light-emitting elements are laid out over a substrate in adjacent columns arranged along a first dimension and adjacent rows arranged along a second dimension, such that each pair of adjacent columns of light-emitting elements, and each row of light-emitting elements, contain each of the red, green, blue and additional color light-emitting elements; and a controller for receiving an input signal for an input image having a two-dimensional spatial content including edge boundaries between first and second regions of the input image and driving the display, the controller being responsive to the two-dimensional spatial content of the input image and increasing apparent display resolution while providing increased display power efficiency.
    • 一种全色电致发光显示系统,包括:显示装置,包括多个红色,绿色,蓝色发光元件和至少一种附加颜色的发光元件,其发光效率大于红色, 绿色和蓝色发光元件,其中发光元件布置在沿着第一尺寸布置的相邻列中的衬底上,并且沿着第二尺寸布置的相邻行,使得每对相邻列的发光元件 每行发光元件包含红色,绿色,蓝色和附加彩色发光元件中的每一个; 以及控制器,用于接收具有包括输入图像的第一和第二区域之间的边界边界的二维空间内容的输入图像的输入信号并且驱动显示器,所述控制器响应输入的二维空间内容 图像和增加视觉显示分辨率,同时提供更高的显示功率效率。
    • 40. 发明申请
    • CCR5 ANTAGONISTS USEFUL FOR TREATING HIV
    • CCR5有效治疗艾滋病毒的拮抗剂
    • US20070203149A1
    • 2007-08-30
    • US11677889
    • 2007-02-22
    • Ragulan RamanathanMichael MillerSwapan ChowdhuryKevin AltonDiane GrotzDiane RindgenAmol Tendolkar
    • Ragulan RamanathanMichael MillerSwapan ChowdhuryKevin AltonDiane GrotzDiane RindgenAmol Tendolkar
    • A61K31/506A61K31/551C07D403/14A61K31/522
    • C07D401/14C07D409/14
    • In its many embodiments, the present invention provides a novel class of compounds of structural formula I as inhibitors of the CCR5 receptors, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with CCR5 using such compounds or pharmaceutical compositions. The invention also relates to the use of a combination of a compound of this invention and one or more antiviral or other agents useful in the treatment of Human Immunodeficiency Virus (HIV). The invention further relates to the use of a compound of this invention, alone or in combination with another agent, in the treatment of solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis.
    • 在其许多实施方案中,本发明提供了一类新颖的结构式I化合物作为CCR5受体的抑制剂,制备这些化合物的方法,含有一种或多种这类化合物的药物组合物,制备药物制剂的方法,其包含一种或多种这样的化合物 化合物,以及使用这些化合物或药物组合物治疗,预防,抑制或改善与CCR5相关的一种或多种疾病的方法。 本发明还涉及本发明化合物与一种或多种可用于治疗人类免疫缺陷病毒(HIV)的抗病毒剂或其它药剂的组合的用途。 本发明还涉及本发明化合物单独或与另一种药剂组合用于治疗实体器官移植排斥,移植物抗宿主病,关节炎,类风湿性关节炎,炎症性肠病,特应性皮炎,牛皮癣 ,哮喘,过敏或多发性硬化。